Influence of α-adrenergic blockade on platelet-mediated thrombosis in stenosed canine coronary arteries

Roberto Bolli, Tedd A. Brandon, Myles L. Mace, Donald G. Weilbaecher

Research output: Contribution to journalArticle

Abstract

Summary: The functional significance of platelet α-adrenergic receptors in vivo is uncertain. The aim of this study was to elucidate their role in experimental coronary thrombosis. In 46 open-chest dogs with a critical coronary stenosis produced by plicating the coronary artery wall with a suture, blood flow showed cyclical reductions followed by an abrupt return to control levels. The flow reductions were previously shown to be caused by platelet aggregation. In the present study they were unaffected by heparin (1,000 U·kg-1·h-1) at the start of the experiment but consistently abolished by aspirin (30 mg·kg-1) at the end of the protocol, further supporting platelet aggregation as the primary mechanism.After 1 h of observation, dogs were assigned to one of the following groups: control (no intervention, n=9), phentolamine (a nonselective α-blocker) "low dose" (0.07 mg·kg-1 bolus followed by 0.1 mg·kg-1·min-1, n=4), phentolamine "high dose" (3 mg·kg-1 bolus followed by 0.07 mg·kg-1·min-1, n=6), prazosin (an α1-blocker, 2 mg·kg-1, n=8), yohimbine (an α2-blocker, 3 mg·kg-1, n= 11) or prazosin + yohimbine (same doses, n=8). In controls, cyclical reductions in flow continued unchanged for another hour. Phentolamine effected a partial dose-related inhibition of flow reductions; however, prazosin and yohimbine, given separately or in combination, failed to produce any significant effect despite an α-blocking action equivalent to or greater than that of phentolamine (α-agonist dose-response studies). Thus, α1-, α2- and combined α1- and α2-blockade, per se, did not interfere with coronary thrombosis in the face of elevated plasma levels of adrenaline and noradrenaline (285 ± 48 and 399 ± 31 ng·litre-1, respectively). It is concluded that, in the dog, α-adrenoceptors do not contribute significantly to spontaneous formation of platelet coronary thrombi even at moderately increased levels of adrenergic stimulation. In addition, this study identifies an in vivo platelet-inhibitory activity of phentolamine that is independent of α-adrenergic blockade.

Original languageEnglish (US)
Pages (from-to)146-154
Number of pages9
JournalCardiovascular Research
Volume19
Issue number3
DOIs
StatePublished - Mar 1985
Externally publishedYes

Fingerprint

Thrombosis
Platelets
Coronary Artery
Phentolamine
Adrenergic Agents
Canidae
Coronary Vessels
Blood Platelets
Yohimbine
Prazosin
Dose
Coronary Thrombosis
Dogs
Platelet Aggregation
Adrenergic Receptors
Aggregation
Agglomeration
Aspirin
Noradrenaline
Heparin

Keywords

  • α-adrenergic blockers
  • α-adrenergic receptors
  • Arterial thrombosis
  • Coronary artery stenosis
  • Coronary blood flow
  • Phentolamine
  • Platelets
  • Prazosin
  • Yohimbine

ASJC Scopus subject areas

  • Statistics, Probability and Uncertainty
  • Applied Mathematics
  • Physiology (medical)
  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Influence of α-adrenergic blockade on platelet-mediated thrombosis in stenosed canine coronary arteries. / Bolli, Roberto; Brandon, Tedd A.; Mace, Myles L.; Weilbaecher, Donald G.

In: Cardiovascular Research, Vol. 19, No. 3, 03.1985, p. 146-154.

Research output: Contribution to journalArticle

Bolli, Roberto ; Brandon, Tedd A. ; Mace, Myles L. ; Weilbaecher, Donald G. / Influence of α-adrenergic blockade on platelet-mediated thrombosis in stenosed canine coronary arteries. In: Cardiovascular Research. 1985 ; Vol. 19, No. 3. pp. 146-154.
@article{f0078130af6e482ca8d2e6407da4b1a1,
title = "Influence of α-adrenergic blockade on platelet-mediated thrombosis in stenosed canine coronary arteries",
abstract = "Summary: The functional significance of platelet α-adrenergic receptors in vivo is uncertain. The aim of this study was to elucidate their role in experimental coronary thrombosis. In 46 open-chest dogs with a critical coronary stenosis produced by plicating the coronary artery wall with a suture, blood flow showed cyclical reductions followed by an abrupt return to control levels. The flow reductions were previously shown to be caused by platelet aggregation. In the present study they were unaffected by heparin (1,000 U·kg-1·h-1) at the start of the experiment but consistently abolished by aspirin (30 mg·kg-1) at the end of the protocol, further supporting platelet aggregation as the primary mechanism.After 1 h of observation, dogs were assigned to one of the following groups: control (no intervention, n=9), phentolamine (a nonselective α-blocker) {"}low dose{"} (0.07 mg·kg-1 bolus followed by 0.1 mg·kg-1·min-1, n=4), phentolamine {"}high dose{"} (3 mg·kg-1 bolus followed by 0.07 mg·kg-1·min-1, n=6), prazosin (an α1-blocker, 2 mg·kg-1, n=8), yohimbine (an α2-blocker, 3 mg·kg-1, n= 11) or prazosin + yohimbine (same doses, n=8). In controls, cyclical reductions in flow continued unchanged for another hour. Phentolamine effected a partial dose-related inhibition of flow reductions; however, prazosin and yohimbine, given separately or in combination, failed to produce any significant effect despite an α-blocking action equivalent to or greater than that of phentolamine (α-agonist dose-response studies). Thus, α1-, α2- and combined α1- and α2-blockade, per se, did not interfere with coronary thrombosis in the face of elevated plasma levels of adrenaline and noradrenaline (285 ± 48 and 399 ± 31 ng·litre-1, respectively). It is concluded that, in the dog, α-adrenoceptors do not contribute significantly to spontaneous formation of platelet coronary thrombi even at moderately increased levels of adrenergic stimulation. In addition, this study identifies an in vivo platelet-inhibitory activity of phentolamine that is independent of α-adrenergic blockade.",
keywords = "α-adrenergic blockers, α-adrenergic receptors, Arterial thrombosis, Coronary artery stenosis, Coronary blood flow, Phentolamine, Platelets, Prazosin, Yohimbine",
author = "Roberto Bolli and Brandon, {Tedd A.} and Mace, {Myles L.} and Weilbaecher, {Donald G.}",
year = "1985",
month = "3",
doi = "10.1093/cvrese/19.3.146",
language = "English (US)",
volume = "19",
pages = "146--154",
journal = "Cardiovascular Research",
issn = "0008-6363",
publisher = "Oxford University Press",
number = "3",

}

TY - JOUR

T1 - Influence of α-adrenergic blockade on platelet-mediated thrombosis in stenosed canine coronary arteries

AU - Bolli, Roberto

AU - Brandon, Tedd A.

AU - Mace, Myles L.

AU - Weilbaecher, Donald G.

PY - 1985/3

Y1 - 1985/3

N2 - Summary: The functional significance of platelet α-adrenergic receptors in vivo is uncertain. The aim of this study was to elucidate their role in experimental coronary thrombosis. In 46 open-chest dogs with a critical coronary stenosis produced by plicating the coronary artery wall with a suture, blood flow showed cyclical reductions followed by an abrupt return to control levels. The flow reductions were previously shown to be caused by platelet aggregation. In the present study they were unaffected by heparin (1,000 U·kg-1·h-1) at the start of the experiment but consistently abolished by aspirin (30 mg·kg-1) at the end of the protocol, further supporting platelet aggregation as the primary mechanism.After 1 h of observation, dogs were assigned to one of the following groups: control (no intervention, n=9), phentolamine (a nonselective α-blocker) "low dose" (0.07 mg·kg-1 bolus followed by 0.1 mg·kg-1·min-1, n=4), phentolamine "high dose" (3 mg·kg-1 bolus followed by 0.07 mg·kg-1·min-1, n=6), prazosin (an α1-blocker, 2 mg·kg-1, n=8), yohimbine (an α2-blocker, 3 mg·kg-1, n= 11) or prazosin + yohimbine (same doses, n=8). In controls, cyclical reductions in flow continued unchanged for another hour. Phentolamine effected a partial dose-related inhibition of flow reductions; however, prazosin and yohimbine, given separately or in combination, failed to produce any significant effect despite an α-blocking action equivalent to or greater than that of phentolamine (α-agonist dose-response studies). Thus, α1-, α2- and combined α1- and α2-blockade, per se, did not interfere with coronary thrombosis in the face of elevated plasma levels of adrenaline and noradrenaline (285 ± 48 and 399 ± 31 ng·litre-1, respectively). It is concluded that, in the dog, α-adrenoceptors do not contribute significantly to spontaneous formation of platelet coronary thrombi even at moderately increased levels of adrenergic stimulation. In addition, this study identifies an in vivo platelet-inhibitory activity of phentolamine that is independent of α-adrenergic blockade.

AB - Summary: The functional significance of platelet α-adrenergic receptors in vivo is uncertain. The aim of this study was to elucidate their role in experimental coronary thrombosis. In 46 open-chest dogs with a critical coronary stenosis produced by plicating the coronary artery wall with a suture, blood flow showed cyclical reductions followed by an abrupt return to control levels. The flow reductions were previously shown to be caused by platelet aggregation. In the present study they were unaffected by heparin (1,000 U·kg-1·h-1) at the start of the experiment but consistently abolished by aspirin (30 mg·kg-1) at the end of the protocol, further supporting platelet aggregation as the primary mechanism.After 1 h of observation, dogs were assigned to one of the following groups: control (no intervention, n=9), phentolamine (a nonselective α-blocker) "low dose" (0.07 mg·kg-1 bolus followed by 0.1 mg·kg-1·min-1, n=4), phentolamine "high dose" (3 mg·kg-1 bolus followed by 0.07 mg·kg-1·min-1, n=6), prazosin (an α1-blocker, 2 mg·kg-1, n=8), yohimbine (an α2-blocker, 3 mg·kg-1, n= 11) or prazosin + yohimbine (same doses, n=8). In controls, cyclical reductions in flow continued unchanged for another hour. Phentolamine effected a partial dose-related inhibition of flow reductions; however, prazosin and yohimbine, given separately or in combination, failed to produce any significant effect despite an α-blocking action equivalent to or greater than that of phentolamine (α-agonist dose-response studies). Thus, α1-, α2- and combined α1- and α2-blockade, per se, did not interfere with coronary thrombosis in the face of elevated plasma levels of adrenaline and noradrenaline (285 ± 48 and 399 ± 31 ng·litre-1, respectively). It is concluded that, in the dog, α-adrenoceptors do not contribute significantly to spontaneous formation of platelet coronary thrombi even at moderately increased levels of adrenergic stimulation. In addition, this study identifies an in vivo platelet-inhibitory activity of phentolamine that is independent of α-adrenergic blockade.

KW - α-adrenergic blockers

KW - α-adrenergic receptors

KW - Arterial thrombosis

KW - Coronary artery stenosis

KW - Coronary blood flow

KW - Phentolamine

KW - Platelets

KW - Prazosin

KW - Yohimbine

UR - http://www.scopus.com/inward/record.url?scp=0021987159&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021987159&partnerID=8YFLogxK

U2 - 10.1093/cvrese/19.3.146

DO - 10.1093/cvrese/19.3.146

M3 - Article

C2 - 2859114

VL - 19

SP - 146

EP - 154

JO - Cardiovascular Research

JF - Cardiovascular Research

SN - 0008-6363

IS - 3

ER -